Proem Acquisition Corp. I 8-K

What Happened
Proem Acquisition Corp. I (PAAC) announced its initial public offering was declared effective on Feb 11, 2026 and closed on Feb 13, 2026. The company sold 13,000,000 units at $10.00 per unit, generating $130,000,000 in gross proceeds. Each unit consists of one ordinary share and one-half of a redeemable warrant (each whole warrant exercisable to buy one share at $11.50, subject to adjustment). Key transaction documents were executed, and $130,000,000 of proceeds (including $4,550,000 of deferred underwriting commissions) were deposited into a trust account held for the benefit of public shareholders.

Key Details

• IPO size: 13,000,000 units at $10.00 per unit = $130,000,000 gross proceeds (Feb 13, 2026).
• Warrants: each unit includes 1/2 warrant; exercise price $11.50 per share (adjustable).
• Private placements: Sponsor bought 292,500 private units for $2,925,000; Clear Street received 97,500 representative ordinary shares in a private placement. Private securities include transfer restrictions and registration rights and were sold under Section 4(a)(2).
• Trust account & timing: $130,000,000 deposited in a trust maintained by Continental Stock Transfer & Trust Company; funds (except limited interest releases for taxes/winding up) are held until the company completes an initial business combination or redeems public shares if no deal is completed within 24 months.
• Governance: John Wu, David Eckstein, Amarnath Thombre and Andrey Kazakov were appointed to the board (all independent). Audit Committee chair: David Eckstein; Compensation Committee chair: John Wu. The company adopted its Amended and Restated Memorandum and Articles of Association.

Why It Matters
This filing confirms PAAC is an active SPAC with proceeds secured in a trust specifically to fund a future acquisition (initial business combination). For investors, the trust protections limit access to IPO cash until a deal or liquidation/redemption event, reducing sponsor discretion over those funds. The issuance of warrants and sponsor/representative share placements can lead to future dilution if warrants are exercised or sponsor shares become tradable. New independent directors and committee appointments establish initial governance for pursuing and approving a target acquisition.